PF4 and COVID-19: Indeed, platelets of COVID-19 patients seem capable of interacting with SARS-CoV-2 via ACE-2-independent mechanisms and upon contact with the virus, increase the secretion of GPVI, CXCL4 and CCL5 in vitro, as well as surface expression of P-selectin (172).